Markets:

Overview

News

Currencies

International

Treasuries

Celestica (NY:CLS)

276.94 -25.29 (-8.37%)

Streaming Delayed Price Updated: 2:13 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Celestica

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday ↗

January 30, 2025

Via Benzinga

Celestica Q4 Earnings Beat Estimates, Boosts FY25 Outlook On Strong CCS Segment Performance ↗

January 30, 2025

Celestica, Inc. (NYSE: CLS) reports strong Q4 results and raises 2025 outlook, with revenue up 19% and adjusted EPS beating estimates. CCS segment saw 30% revenue growth.

Via Benzinga

Topics Earnings

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 30, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Information Technology Stocks Moving In Thursday's Pre-Market Session ↗

January 30, 2025

Via Benzinga

Deep Dive Into Celestica Stock: Analyst Perspectives (5 Ratings) ↗

January 28, 2025

Via Benzinga

NYSE:CLS stands out as a growth opportunity that won't break the bank. ↗

January 15, 2025

Looking for growth without the hefty price tag? Consider CELESTICA INC (NYSE:CLS).

Via Chartmill

Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

January 30, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

January 29, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Celestica Announces Fourth Quarter and FY 2024 Financial Results

January 29, 2025

Q4 2024 adjusted EPS* above the high end of the guidance range; Raising 2025 annual outlook

From Celestica International LP

Via GlobeNewswire

(CLS) - Analyzing Celestica's Short Interest ↗

January 15, 2025

Via Benzinga

NYSE:CLS is not too expensive for the growth it is showing. ↗

December 25, 2024

For those who appreciate growth without the sticker shock, NYSE:CLS is worth considering.

Via Chartmill

While growth is established for NYSE:CLS, the stock's valuation remains reasonable. ↗

December 04, 2024

NYSE:CLS, a growth stock which is not overvalued.

Via Chartmill

Peering Into Celestica's Recent Short Interest ↗

November 29, 2024

Via Benzinga

Earnings Scheduled For January 29, 2025 ↗

January 29, 2025

Via Benzinga

Analyst Ratings For Celestica ↗

November 22, 2024

Via Benzinga

Spotlight on Celestica: Analyzing the Surge in Options Activity ↗

November 19, 2024

Via Benzinga

Celestica Stock Surges As Board Member Steps Down Ahead Of Earnings: Retail Turns Extremely Bullish ↗

January 22, 2025

Last week, analysts at RBC Capital raised their price target for the Celestica stock to $115 from $75 with an ‘Outperform’ rating.

Via Stocktwits

Celestica Recognized as One of Canada’s Top Employers for Young People for the Second Consecutive Year

January 21, 2025

From Celestica International LP

Via GlobeNewswire

Celestica Inc: Chart Analysis ↗

January 15, 2025

Technical analysis of the stock chart for CLS.

Via Talk Markets

Topics Stocks / Equities

Celestica Q4 2024 Financial Results and Conference Call Thursday, January 30, 2025

January 13, 2025

From Celestica International LP

Via GlobeNewswire

NYSE:CLS is showing good growth, while it is not too expensive. ↗

November 13, 2024

For those who appreciate growth without the sticker shock, NYSE:CLS is worth considering.

Via Chartmill

Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗

January 12, 2025

Top performers in last week's stock market: Walgreens, Constellation Energy, FTAI Aviation, TD SYNNEX, Aurora Innovation, Royalty Pharma, Micron, Delta Air Lines, Intra-Cellular Therapies, United...

Via Benzinga

Amar Maletira Appointed to Celestica’s Board of Directors

January 02, 2025

From Celestica International LP

Via GlobeNewswire

Jabil Stock Gets Relative Strength Rating Upgrade ↗

December 19, 2024

The Relative Strength (RS) Rating for Jabil stock climbed into a new percentile Thursday, with an increase from 73 to 85.

Via Investor's Business Daily

Be Careful In This Unforgiving Market. The Tide Is Turning. ↗

December 15, 2024

Via Talk Markets

Topics Stocks / Equities

Jabil Stock Scores Relative Strength Rating Upgrade ↗

November 07, 2024

Jabil stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 67 to 77.

Via Investor's Business Daily

This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

November 05, 2024

Via Benzinga

Buckle Up And Use Volitility To Your Advantage ↗

November 03, 2024

The Advance/Decline trend on the NYSE weakened; the Nasdaq A/D line is outright scary.

Via Talk Markets

Celestica Announces TSX Acceptance of Early Renewal of Its Normal Course Issuer Bid

October 30, 2024

From Celestica International LP

Via GlobeNewswire

Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? ↗

October 27, 2024

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Via Benzinga

Topics Government

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.